Subcutaneous administration of foslevodopa/foscarbidopa (PRODUODOPA) in arm and thigh due to giant epigastric hernia: a case report.

BACKGROUND

PRODUODOPA is a combination of foscarbidopa and foslevodopa indicated for the treatment of motor fluctuations in patients with advanced Parkinson's disease when available combinations of peroral drugs have not given satisfactory results. The solution is administered via subcutaneous infusion, most frequently in the abdomen, using an infusion pump. The study results showed a significant effect on the reductions in off time and higher control of motor symptoms without troublesome dyskinesia.

CASE DESCRIPTION

A 61-year-old man on long-term oral therapy for Parkinson's disease presented with frequent wearing-off phenomenon, daily freezing episodes and occasional episodes of severe nocturnal akinesia. Due to giant epigastric hernia PRODUODOPA was administered subcutaneously in upper arm and thigh. The use of the pump resulted in an excellent therapeutic effect with a reduction in motor fluctuations and an improvement in the patient's quality of life. From the available medical literature, the use of the drug in the limb area has not been described so far.

CONCLUSION

PRODUODOPA can be administered subcutaneously in the area of ​​the upper and lower extremities with just as good results as after subcutaneous infusion in abdomen.